About this Research Topic
In the realm of science and research, women remain underrepresented, a concerning trend spanning across various disciplines including gastrointestinal and hepatic pharmacology. Currently, women constitute less than 30% of researchers globally, with enduring biases and gender stereotypes continuing to steer them away from STEM fields. This discrepancy not only hinders gender equality but also stalls comprehensive scientific advancement, critical for sustainable development as emphasized by UNESCO. Addressing these challenges requires more than just raising awareness; it necessitates active interventions to dismantle existing stereotypes and promote inclusivity within the scientific community.
This Research Topic aims to showcase the invaluable contributions of women in the fields of gastrointestinal and hepatic pharmacology, enhancing visibility and fostering a more inclusive research environment. By highlighting their work, the initiative seeks to not only recognize but also amplify the impact of women scientists in advancing our understanding and treatment of GI and liver disorders, thereby paving the way for future innovations and therapeutic strategies.
The scope of this Research Topic is consciously broad, striving to encompass a wide array of investigations within gastrointestinal and hepatic pharmacology. To gather further insights in this critical area of medical research, we welcome articles addressing, but not limited to, the following themes:
• Novel drug targets and therapeutic strategies for gastrointestinal and hepatic disorders
• Mechanisms of drug action and pharmacokinetics in the gastrointestinal tract and liver
• Personalized medicine in gastrointestinal and hepatic diseases
• Drug-induced liver injury and adverse drug reactions
• Emerging technologies and methodologies in pharmacological research related to the gastrointestinal tract and liver
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
This Research Topic aims to showcase the invaluable contributions of women in the fields of gastrointestinal and hepatic pharmacology, enhancing visibility and fostering a more inclusive research environment. By highlighting their work, the initiative seeks to not only recognize but also amplify the impact of women scientists in advancing our understanding and treatment of GI and liver disorders, thereby paving the way for future innovations and therapeutic strategies.
The scope of this Research Topic is consciously broad, striving to encompass a wide array of investigations within gastrointestinal and hepatic pharmacology. To gather further insights in this critical area of medical research, we welcome articles addressing, but not limited to, the following themes:
• Novel drug targets and therapeutic strategies for gastrointestinal and hepatic disorders
• Mechanisms of drug action and pharmacokinetics in the gastrointestinal tract and liver
• Personalized medicine in gastrointestinal and hepatic diseases
• Drug-induced liver injury and adverse drug reactions
• Emerging technologies and methodologies in pharmacological research related to the gastrointestinal tract and liver
Please note: to be considered for this collection, the first or last author should be a researcher who identifies as a woman.
Keywords: #CollectionSeries, Women in Science, Research, Gastrointestinal, Hepatic, Pharmacology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
